Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.
Clinical trial NCT00395551 · COMPLETED
Trial details
- NCT number
- NCT00395551
- Sponsor
- Ophthalmic Consultants of Boston
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2009-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.